ARGX
argenx SE
NASDAQ · Healthcare · Biotechnology · NL
$1,033.15
−1.93%Margins
Gross margin
89.6%
EBITDA margin
30.5%
EBIT margin
26.3%
Net margin
29.6%
FCF margin
10.9%
27.3%
Return on equity
22.9%
Return on assets
24.1%
Return on invested capital
0.83x
Asset turnover
$850.5M
Cash from operations
$83
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026